⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13674146 | 0.64 | — | — | |
| SCHEMBL487551 | 0.64 | — | — | |
| SCHEMBL5991803 | 0.62 | — | — | |
| SCHEMBL831267 | 0.62 | — | — | |
| SCHEMBL22028079 | 0.58 | — | — | |
| SCHEMBL793905 | 0.57 | — | — | |
| SCHEMBL169861 | 0.56 | — | — | |
| SCHEMBL4665561 | 0.56 | — | — | |
| SCHEMBL143587 | 0.55 | — | — | |
| SCHEMBL4933840 | 0.54 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100279986-A1 | HETEROCYCLIC DERIVED METALLOPROTEASE INHIBITORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2010-11-04 | — | — | US | disclosed |